Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above ​Wall Street estimates and this ‌year's projected earnings, signalling steady progress in the ‌health conglomerate's turnaround plan.

CVS stock rose 5% in early trading on Tuesday.

The company in October projected double-digit earnings growth for 2026 after raising its 2025 ⁠profit forecast for ‌the third time.

"We are closing out 2025 with meaningful ‍momentum across our businesses and we expect another year of strong earnings growth in ​2026," said Chief Financial Officer ‌Brian Newman on Tuesday.

The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, ⁠according to data compiled ​by LSEG.

It, however, ​expects total revenue of at least $400 billion next year, below analysts' ‍average estimate ⁠of $419.26 billion.

Sign up for Yahoo Finance Breaking News

By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy

Subscribe

CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 ⁠per share from $6.55 to $6.65 previously.

(Reporting by Sneha ‌S K in Bengaluru; Editing ‌by Shinjini Ganguli)